Lung Therapeutics, Inc. STTR Phase I Award, September 2018
A STTR Phase I contract was awarded to Lung Therapeutics, Inc. in September, 2018 for $224,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
Is a
Award Amount (USD)
224,997
0
Government Branch
Date Awarded
September 21, 2018
0
End Date
August 31, 2019
0
SBIR/STTR Award Recipient
Contract Number (US Government)
1R41HL140673-01A1
0
Award Phase
Phase I
0
Award Type
STTR
0
Official Website
Find more entities like Lung Therapeutics, Inc. STTR Phase I Award, September 2018
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
